Heck Capital Advisors’s Amedisys AMED Stock Holding History

Heck Capital Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19	Closed	-$1.73K	–	264
2024 Q4	$1.73K	Buy	+19	New	+$1.75K	﹤0.01%	657

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Heck Capital Advisors's AMED Position: Q1 2025 in Review

Heck Capital Advisors sold out of Amedisys (AMED) in Q1 2025, closing a stake of 19 shares — an estimated $1.73K sold.

Heck Capital Advisors first reported a position in AMED in Q4 2024 and held it in 1 quarter. The position peaked at $1.73K in Q4 2024. 305 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

Heck Capital Advisors reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
Heck Capital Advisors sold 19 Amedisys shares in Q1 2025, an estimated $1.73K.
Heck Capital Advisors first reported a position in Amedisys in Q4 2024 and held it in 1 quarter.
Heck Capital Advisors's Amedisys position peaked at $1.73K in Q4 2024.
305 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Heck Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.